These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 17405939)

  • 1. Biomarkers for cystic fibrosis: are we progressing?
    Alton EW; Davies JC; Geddes DM
    Am J Respir Crit Care Med; 2007 Apr; 175(8):750-1. PubMed ID: 17405939
    [No Abstract]   [Full Text] [Related]  

  • 2. Yet another role for the cystic fibrosis transmembrane conductance regulator.
    Widdicombe JH
    Am J Respir Cell Mol Biol; 2000 Jan; 22(1):11-4. PubMed ID: 10615060
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cystic fibrosis and gene therapy].
    Setoguchi Y; Yokoyama T
    Nihon Rinsho; 2005 Dec; 63 Suppl 12():607-16. PubMed ID: 16416861
    [No Abstract]   [Full Text] [Related]  

  • 4. What happens to deltaF508 in vivo?
    Drumm M
    J Clin Invest; 1999 May; 103(10):1369-70. PubMed ID: 10330418
    [No Abstract]   [Full Text] [Related]  

  • 5. Cystic fibrosis gene therapy trials and tribulations.
    Zeitlin PL
    Mol Ther; 2000 Jan; 1(1):5-6. PubMed ID: 10933904
    [No Abstract]   [Full Text] [Related]  

  • 6. Cystic fibrosis: premature degradation of mutant proteins as a molecular disease mechanism.
    Gelman MS; Kopito RR
    Methods Mol Biol; 2003; 232():27-37. PubMed ID: 12840537
    [No Abstract]   [Full Text] [Related]  

  • 7. What can we learn about fertilization from cystic fibrosis?
    Florman HM; Jungnickel MK; Sutton KA
    Proc Natl Acad Sci U S A; 2007 Jul; 104(27):11123-4. PubMed ID: 17595298
    [No Abstract]   [Full Text] [Related]  

  • 8. Sweat chloride concentration in cystic fibrosis patients with cystic fibrosis trans-membrane conductance regulator 11234V mutation.
    Al-Mendalawi MD; Abdul-Wahab A; Janahi IA; Abdel-Rahman MO
    Saudi Med J; 2010 Mar; 31(3):339-40; author reply 340. PubMed ID: 20231949
    [No Abstract]   [Full Text] [Related]  

  • 9. Fixing cystic fibrosis CFTR with correctors and potentiators. Off to a good start.
    Elborn JS
    Thorax; 2012 Jan; 67(1):4-5. PubMed ID: 22058188
    [No Abstract]   [Full Text] [Related]  

  • 10. Cystic fibrosis: from the gene to the dream.
    Buchwald M
    Clin Invest Med; 1996 Oct; 19(5):304-10. PubMed ID: 8889267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [From the laboratory to the clinic: CFTR and the therapeutic options for cystic fibrosis].
    Mayol J; Alvarez de Arcaya Vicente A; Arbeo Escolar AM; Peña Soria MJ; Alvarez Fernández-Represa J
    An Med Interna; 2000 Feb; 17(2):92-8. PubMed ID: 10829466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cystic fibrosis lung disease and its management].
    Hidaka N; Hidaka Y
    Nihon Rinsho; 1999 Sep; 57(9):2139-44. PubMed ID: 10497420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New tests for cystic fibrosis.
    Davies JC
    Paediatr Respir Rev; 2006; 7 Suppl 1():S141-3. PubMed ID: 16798543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cystic fibrosis transmembrane conductance regulator protein expression in the male excretory duct system during development.
    Marcorelles P; Gillet D; Friocourt G; Ledé F; Samaison L; Huguen G; Ferec C
    Hum Pathol; 2012 Mar; 43(3):390-7. PubMed ID: 21840567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repeat administration of an adenovirus vector encoding cystic fibrosis transmembrane conductance regulator to the nasal epithelium of patients with cystic fibrosis.
    Zabner J; Ramsey BW; Meeker DP; Aitken ML; Balfour RP; Gibson RL; Launspach J; Moscicki RA; Richards SM; Standaert TA
    J Clin Invest; 1996 Mar; 97(6):1504-11. PubMed ID: 8617884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cystic fibrosis: year in review.
    Boyle MP
    Curr Opin Pulm Med; 2010 Nov; 16(6):583. PubMed ID: 20829695
    [No Abstract]   [Full Text] [Related]  

  • 17. Developmental paradigm for early features of cystic fibrosis.
    Larson JE; Cohen JC
    Pediatr Pulmonol; 2005 Nov; 40(5):371-7. PubMed ID: 15830387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammation and CFTR: might neutrophils be the key in cystic fibrosis?
    Witko-Sarsat V; Sermet-Gaudelus I; Lenoir G; Descamps-Latscha B
    Mediators Inflamm; 1999; 8(1):7-11. PubMed ID: 10704083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New therapeutic approaches in cystic fibrosis].
    Vestner A; Schrepfer B; Kockler J; Mohr F; Zündorf I; Dingermann T
    Pharm Unserer Zeit; 2008; 37(5):354-5. PubMed ID: 18729285
    [No Abstract]   [Full Text] [Related]  

  • 20. The amiloride-inhibitable Na+ conductance is reduced by the cystic fibrosis transmembrane conductance regulator in normal but not in cystic fibrosis airways.
    Mall M; Bleich M; Greger R; Schreiber R; Kunzelmann K
    J Clin Invest; 1998 Jul; 102(1):15-21. PubMed ID: 9649552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.